|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/76 | |
| A61K 39/12 | |||
| C12N 7/02 | |||
| A61K 47/20 | |||
| A61K 47/26 | |||
| A61K 47/18 | |||
| A61K 9/19 |
| (11) | Number of the document | 2898890 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15158279.8 |
| Date of filing the European patent application | 2011-03-31 | |
| (97) | Date of publication of the European application | 2015-07-29 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201005521 | 2010-03-31 | GB | |
| 10250706 | 2010-03-31 | EP | |
| 201005520 | 2010-03-31 | GB | |
| 201005497 | 2010-03-31 | GB | |
| 201014962 | 2010-09-08 | GB | |
| 201017648 | 2010-10-19 | GB | |
| 201017647 | 2010-10-19 | GB |
| (72) |
Drew, Jeffrey, GB
Woodward, David, GB
Bainbridge, John, GB
Corteyn, Amanda, GB
|
| (73) |
Stabilitech Biopharma Ltd,
Unit 6, Sovereign Business Park Albert Drive Burgess Hill, West Sussex, RH15 9TY,
GB
|
| (54) | Stabilisation of viral particles |
| Stabilisation of viral particles |